Skip to main content

Table 1 Clinical characteristics of the patients included in the study

From: Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis

 

DCF, N = 37

bDCF, N = 22

p value

Age (years)a

61.2 ± 9.5

67.1 ± 7.3

0.016

Sex

  

0.725

 Male/female

30/7

17/5

 

Tumor locationb

  

0.045

 Ut/Mt./Lt/Ae

5/21/10/1

2/10/4/6

 

Clinical T stagec

  

0.502

 T1/T2/T3/T4a/T4b

1/3/14/8/11

1/0/6/5/10

 

Clinical N stagec

  

0.625

 N0/N1/N2/N3

2/29/5/1

2/15/5/0

 

Clinical M stagec

  

0.599

 M0/M1 (LYM)

34/4

21/1

 

Clinical stagec

  

0.151

 IIA/IIB/IIIA/IIIB/IIIC/IV

1/3/20/2/8/3

1/0/7/1/12/1

 

ASAPS

  

0.082

 1/2/3

13/21/3

2/18/2

 

Comorbidities

 Heart disease

8

15

< 0.001

 Pulmonary disease

1

4

0.039

 Diabetes mellitus

5

5

0.362

  1. Ae abdominal esophagus, ASAPS American Society of Anesthesiologists performance states, Lt lower thoracic esophagus, LYM lymph node metastasis, Mt. middle thoracic esophagus, Ut upper thoracic esophagus
  2. aMean ± standard deviation
  3. bAccording to the Japanese Classification of Esophageal Cancer, 11th edition
  4. cAccording to the UICC classification, 7th edition